Rare-earth nanocrystalline scintillators for biomedical application: A review
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Radiation Detection and Scintillator Technologies · Luminescence Properties of Advanced Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Inorganic nanoparticles in cancer therapy10.1007/s11095-010-0318-0 ↗
2. Recent development of inorganic nanoparticles for biomedical imaging10.1021/acscentsci.7b00574 ↗
3. Biomedical inorganic nanoparticles: preparation, properties, and perspectives
4. Recent advances in upconversion nanoparticle-based nanocomposites for gas therapy10.1039/D1SC04413C ↗
5. A lanthanide upconversion nanothermometer for precise temperature mapping on immune cell membrane10.1021/acs.nanolett.2c03392 ↗
6. Thermoresponsive polymeric nanolenses magnify the thermal sensitivity of single upconverting nanoparticles10.1002/smll.202202452 ↗
7. Rare earth nanoparticles for sprayed and intravenous NIR II imaging and photodynamic therapy of tongue cancer10.1039/D2NA00197G ↗
8. Recent advances in fluorescent upconversion nanomaterials: novel strategies for enhancing optical and magnetic properties to biochemical sensing and imaging applications10.1080/05704928.2020.1851238 ↗
9. Lanthanide upconversion nanoplatforms for advanced bacteria-targeted detection and therapy
10. Lanthanide-based photothermal materials: fabrication and biomedical applications10.1021/acsabm.0c00618 ↗
11. Temperature-feedback upconversion nanocomposite for accurate photothermal therapy at facile temperature
12. NIR‐triggered phototherapy and immunotherapy via an antigen‐capturing nanoplatform for metastatic cancer treatment
13. Lanthanide-based nanocomposites for photothermal therapy under near-infrared laser: relationship between light and heat, biostability, and reaction temperature10.1021/acs.langmuir.0c00343 ↗
14. Current advances in the biomedical applications of quantum dots: promises and challenges10.3390/ijms241612682 ↗
15. Advances in the design and use of carbon dots for analytical and biomedical applications10.1088/1361-6528/acfdaf ↗
16. Green, yellow and red emitting CdTe QDs decreased the affinities of apigenin and luteolin for human serum albumin in vitro10.1016/j.jhazmat.2010.06.088 ↗
17. Luminescent quantum dots, making invisibles visible in bioimaging10.1016/B978-0-12-416020-0.00002-4 ↗
18. Quantum Dot Nanomaterials: preparation, characterization, advanced bio-imaging and therapeutic applications
19. Advancing x-ray luminescence for imaging, biosensing, and theragnostics10.1021/acs.accounts.2c00517 ↗
20. Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors10.1016/j.biomaterials.2010.05.065 ↗
21. Enhanced upconversion emission in Er3+/Yb3+-codoped Al2Mo3O12 microparticles via doping strategy: towards multimode visual optical thermometer10.1016/j.jlumin.2022.119333 ↗
22. Luminescent thermometry based on Er3+/Yb3+ co-doped yttrium niobate with high NIR emission and NIR-to-visible upconversion quantum yields10.1016/j.jlumin.2022.118986 ↗
23. Rapid synthesis of transparent Lu2O3:RE3+ (RE = Eu, Tb and Tm) thin-film scintillators with tunable RGB luminescence for the detection of X-ray10.1016/j.jlumin.2022.119220 ↗
24. Scintillation materials based on metal iodates by rare earth doping modifications for use in radioluminescence and X-ray imaging10.1039/D1CE00153A ↗
25. Ultrasmall semimetal nanoparticles of bismuth for dual-modal computed tomography/photoacoustic imaging and synergistic thermoradiotherapy10.1021/acsnano.7b00476 ↗
26. Chemistry of MRI contrast agents: current challenges and new frontiers10.1021/acs.chemrev.8b00363 ↗
27. Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents10.1039/C7CS00316A ↗
28. Energy partitioning in multicomponent nanoscintillators for enhanced localized radiotherapy10.1021/acsami.3c00853 ↗
29. Current advances in lanthanide ion Ln3+-based upconversion nanomaterials for drug delivery10.1039/C4CS00155A ↗
30. Inorganic scintillators: today and tomorrow10.1016/S0022-2313(02)00423-4 ↗
31. Next generation lanthanide doped nanoscintillators and photon converters10.1186/s43593-022-00024-0 ↗
32. X-ray-computed tomography contrast agents10.1021/cr200358s ↗
33. Inorganic scintillators in medical imaging detectors10.1016/S0168-9002(03)01542-0 ↗
34. Recent R&D trends in inorganic single-crystal scintillator materials for radiation detection10.1002/adom.201400571 ↗
35. High energy X-ray radiation sensitive scintillating materials for medical imaging, cancer diagnosis and therapy10.1016/j.nanoen.2020.105437 ↗
36. Development of new scintillators for medical applications10.1016/j.nima.2015.08.041 ↗
37. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?10.7150/thno.7193 ↗
38. Drug delivery systems: entering the mainstream10.1126/science.1095833 ↗
39. Near-infrared emission of redispersible Er3+, Nd3+, and Ho3+ Doped LaF3 nanoparticles10.1021/nl025562q ↗
40. Magnetic and luminescent properties of multifunctional GdF3:Eu3+ nanoparticles10.1063/1.3177194 ↗
41. Hydrothermal synthesis of lanthanide fluorides LnF3 (Ln = La to Lu) nano/microcrystals with multiform structures and morphologies10.1021/cm800279h ↗
42. Water-soluble GdF3 and GdF3/LaF3 nanoparticles physical characterization and NMR relaxation properties10.1021/cm052299w ↗
43. Near-infrared-to-blue upconversion in colloidal BaYF5:Tm3+, Yb3+ nanocrystals10.1021/cm900313s ↗
44. Orthorhombic KSc2F7:Yb/Er nanorods: controlled synthesis and strong red upconversion emission10.1039/c3nr01840g ↗
45. Visible quantum cutting through downconversion in green-emitting K2GdF5:Tb3+ phosphors
46. Hexagonal-phase NaREF4 upconversion nanocrystals: the matter of crystal structure10.1039/D1NR04209B ↗
47. Low-dose X-ray excited photodynamic therapy based on NaLuF4:Tb3+–rose bengal nanocomposite10.1021/acs.bioconjchem.9b00429 ↗
48. Poly(Acrylic Acid) modification of Nd 3+‐sensitized upconversion nanophosphors for highly efficient UCL imaging and pH‐responsive drug delivery10.1002/adfm.201501582 ↗
49. Rare‐earth nanoparticles with enhanced upconversion emission and suppressed rare‐earth‐ion leakage10.1002/chem.201103485 ↗
50. Luminescence and scintillation properties of LuPO4-Ce nanoparticles10.1016/j.jlumin.2013.07.027 ↗
51. Crystallization-dependent luminescence properties of Ce:LuPO410.1021/acs.inorgchem.5b02860 ↗
52. UV emitting nanoparticles enhance the effect of ionizing radiation in 3D lung cancer spheroids10.1080/09553002.2022.2027541 ↗
53. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy10.1186/s12951-018-0344-3 ↗
54. Magnetic-luminescent cerium-doped gadolinium aluminum garnet nanoparticles for simultaneous imaging and photodynamic therapy of cancer cells10.1016/j.jcis.2018.04.100 ↗
55. Different Roles of Ce3+ Optical centers in oxyorthosilicate nanocrystals at X-ray and UV excitation10.3390/cryst9020114 ↗
56. Preparation and luminescence properties of A-type lutecium silicate core–shell nanospheres10.1021/acs.inorgchem.9b03336 ↗
57. Controllable synthesis of bifunctional monodisperse gadolinium orthosilicate core-shell nanospheres
58. Development of dispersible radioluminescent silicate nanoparticles through a sacrificial layer approach10.1016/j.jcis.2020.07.125 ↗
59. Aqueous‐based inorganic colloidal halide perovskites customizing liquid scintillators10.1002/adma.202304743 ↗
60. Layered perovskite doping with Eu3+ and β-diketonate Eu3+ complex10.1021/acs.chemmater.0c04097 ↗
61. Stability of perovskite light‐emitting diodes: existing issues and mitigation strategies related to both material and device aspects
62. Dual-targeted nanoformulation with Janus structure for synergistic enhancement of sonodynamic therapy and chemotherapy
63. Lanthanide-doped core–shell–shell nanocomposite for dual photodynamic therapy and luminescence imaging by a single x-ray excitation source10.1021/acsami.8b00015 ↗
64. X-ray-induced dhortwave infrared biomedical imaging using rare-earth nanoprobes10.1021/nl504123r ↗
65. Tuning the morphology, luminescence and magnetic properties of hexagonal-phase NaGdF4:Yb, Er nanocrystals via altering the addition sequence of the precursors10.1088/0957-4484/28/1/015601 ↗
66. Sub-10 nm water-dispersible β-NaGdF4:X% Eu3+ nanoparticles with enhanced biocompatibility for in vivo x-ray luminescence computed tomography10.1021/acsami.7b11295 ↗
67. PEGylated β-NaGdF4/Tb@CaF2 core/shell nanophosphors for enhanced radioluminescence and folate receptor targeting10.1021/acsanm.9b00629 ↗
68. Preparation of core-shell NaGdF4 nanoparticles doped with luminescent lanthanide ions to be used as upconversion-based probes10.1038/nprot.2014.111 ↗
69. High-resolution X-ray luminescence extension imaging10.1038/s41586-021-03251-6 ↗
70. Multicolor core/shell‐structured upconversion fluorescent nanoparticles10.1002/adma.200801056 ↗
71. Flexible X-ray luminescence imaging enabled by cerium-sensitized nanoscintillators10.1016/j.jlumin.2021.118589 ↗
72. PEG-PLGA nanospheres loaded with nanoscintillators and photosensitizers for radiation-activated photodynamic therapy10.1016/j.actbio.2020.09.029 ↗
73. The effects of the solution reactant concentration and temperature on the preparation of Pr3+:BaF2 transparent ceramics10.1111/jace.17817 ↗
74. CT/MRI‐guided synergistic radiotherapy and X‐ray inducible photodynamic therapy using Tb‐doped Gd‐W‐nanoscintillators10.1002/ange.201812272 ↗
75. mussel-inspired polydopamine-coated lanthanide nanoparticles for NIR-II/CT dual imaging and photothermal therapy10.1021/acsami.7b06109 ↗
76. Upconverting lanthanide fluoride core@shell nanorods for luminescent thermometry in the first and second biological windows: β-NaYF4:Yb3+–Er3+ @SiO2 temperature sensor10.1021/acsami.9b00445 ↗
77. Solvothermal fabrication and luminescent properties of nano LuAG:Ce phosphors10.1049/mnl.2013.0642 ↗
78. Controlled synthesis and photoluminescence properties of Bi2SiO5:Eu3+ core-shell nanospheres with an intense 5D0 → 7F4 transition10.1364/OME.414564 ↗
79. Controlled synthesis and the effects of Gd3+ substitution, calcination, and particle size on photoluminescence of (Y0.95−xGdxTb0.05)2O3 green phosphor spheres10.1016/j.cej.2016.07.078 ↗
80. Uniform colloidal spheres for (Y1−xGdx)2O3 (x = 0-1): formation mechanism, compositional impacts, and physicochemical properties of the oxides10.1021/cm7033257 ↗
81. Sequential enlarging Lu2O3:Eu phosphor mono-spheres into near micro-meter size range by controlled nucleation and growth for attaining optimum photoluminescence properties10.1016/j.ceramint.2022.06.060 ↗
82. Controllable synthesis and luminescence properties of monodisperse lutetium oxide spheres with tunable particle sizes and multicolor emissions10.1016/j.jallcom.2021.159029 ↗
83. Multiform oxide optical materials via the versatile pechini-type sol−gel process: synthesis and characteristics10.1021/jp070062c ↗
84. Synthesis and scintillation properties of cerium-doped Gd2SiO5 nanopowders under alpha radiation and the importance of selecting the appropriate calcination temperature10.1016/j.jlumin.2019.116849 ↗
85. YVO4 nanoparticles doped with Eu3+ and Nd3+ for optical nanothermometry10.1021/acsanm.1c02992 ↗
86. Simultaneous paramagnetic and persistence-luminescence in GAGG:Ce,Pr nanoparticles synthesized by sol-gel for biomedical applications10.1063/1.5098788 ↗
87. Dual-photosensitizer coupled nanoscintillator capable of producing type I and type II ROS for next generation photodynamic therapy10.1016/j.jcis.2018.10.090 ↗
88. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects10.1021/bc100070g ↗
89. Uptake and inflammatory effects of nanoparticles in a human vascular endothelial cell line
90. Daylight induced antibacterial activity of gadolinium oxide, samarium oxide and erbium oxide nanoparticles and their aquatic toxicity10.1016/j.matchemphys.2017.05.039 ↗
91. A review on biomedical applications, prospects, and challenges of rare earth oxides
92. Cytotoxicity and genotoxicity caused by yttrium oxide nanoparticles in HEK293 cells10.2147/IJN.S52625 ↗
93. A luminescent and mesoporous core-shell structured Gd2O3:Eu3+@nSiO2@mSiO2 nanocomposite as a drug carrier10.1039/c1dt10162e ↗
94. Annealing-modulated nanoscintillators for nonconventional X-ray activation of comprehensive photodynamic effects in deep cancer theranostics10.7150/thno.41752 ↗
95. Upconversion luminescence and temperature sensing properties of NaGd(WO4)2 :Yb3+/Er3+@SiO2 core–shell nanoparticles10.1039/D0RA10039K ↗
96. Soft X-ray activated NaYF4:Gd/Tb scintillating nanorods for in vivo dual-modal X-ray/X-ray-induced optical bioimaging10.1039/C7NR02926H ↗
97. Incoherent broadband mid-infrared detection with lanthanide nanotransducers, Nat10.1038/s41566-022-01042-7 ↗
98. Recent advances of near infrared inorganic fluorescent probes for biomedical applications10.1039/D0TB01430C ↗
99. Second window for in vivo imaging10.1038/nnano.2009.326 ↗
100. Near-infrared luminescence high-contrast in vivo biomedical imaging10.1038/s44222-022-00002-8 ↗